Search - tctmd.com

Displaying 61 - 80 of 591

Sort: Relevancy | Date

OCEANIC-AF: Asundexian vs. Apixaban in Patients with Atrial Fibrillation

Presentation ESC 2024

OCEANIC-AF: Asundexian vs. Apixaban in Patients with Atrial Fibrillation

Presenter: Manesh R. Patel

September 01, 2024

September 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

September 01, 2024

Stroke prevention & rhythm control Therapy: Evaluation of an Educational programme of the European society of cardiology in a cluster-Randomised trial in patients with Atrial Fibrillation

Presentation ESC 2024

Stroke prevention & rhythm control Therapy: Evaluation of an Educational programme of the European society of cardiology in a cluster-Randomised trial in patients with Atrial Fibrillation

Presenter: Dipak Kotecha

September 01, 2024

Trial Challenges Continuation of Oral Anticoagulants During TAVI

News Conference News ESC 2024

Trial Challenges Continuation of Oral Anticoagulants During TAVI

August 31, 2024

Continuation versus Interruption of Oral Anticoagulation during TAVI

Presentation ESC 2024

Continuation versus Interruption of Oral Anticoagulation during TAVI

Presenter: Dirk-Jan van Ginkel

August 31, 2024

Good News for CV Recovery After COVID-19 Vaccine Myocarditis

News Daily News

Good News for CV Recovery After COVID-19 Vaccine Myocarditis

Yael L. Maxwell

August 29, 2024

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

Sudden Deaths After Acute MI Have Dropped, but Early Weeks Remain Risky

News Daily News

Sudden Deaths After Acute MI Have Dropped, but Early Weeks Remain Risky

Yael L. Maxwell

August 08, 2024

ACC/AHA Update Performance, Quality Measures for HF Care

News Daily News

ACC/AHA Update Performance, Quality Measures for HF Care

August 08, 2024

August 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

August 01, 2024

Lower-Dose Edoxaban May Be an Option After Age 80: ENGAGE AF-TIMI 48 Analysis

News Daily News

Lower-Dose Edoxaban May Be an Option After Age 80: ENGAGE AF-TIMI 48 Analysis

July 12, 2024

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

News Daily News

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

Michael O'Riordan

July 09, 2024

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

News Daily News

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

July 02, 2024

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

Long-term Digoxin Use Linked to VT/VF Risk in HF Patients

News Daily News

Long-term Digoxin Use Linked to VT/VF Risk in HF Patients

June 11, 2024

Leaks After LAAO Do Matter, Experts Agree

News Conference News NY Valves 2024

Leaks After LAAO Do Matter, Experts Agree

June 10, 2024

AHA Celebrates a Century by Looking Back, and Forward

News Daily News

AHA Celebrates a Century by Looking Back, and Forward

June 10, 2024

Long-term Mortality After TAVI Lower With DOACs vs VKAs

News Conference News NY Valves 2024

Long-term Mortality After TAVI Lower With DOACs vs VKAs

June 06, 2024

June 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

June 01, 2024

Goal of Arrhythmia Care in Athletes is a Return to Play: HRS Consensus

News Conference News HRS 2024

Goal of Arrhythmia Care in Athletes is a Return to Play: HRS Consensus

Michael O'Riordan

May 23, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.